TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
Helena Idborg, Susanna Eketjäll, Susanne Pettersson...
https://pubmed.ncbi.nlm.nih.gov/29955370/Actively Recruiting
Led by Sohag University · Updated on 2026-05-13
200
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying the potential of using a combination of the albumin to globulin ratio AGR and the prognostic nutritional index PNI as a predictive tool for disease activity in patients with systemic lupus erythematosus SLE. This observational study aims to correlate these nutritional and inflammatory markers with clinical signs and laboratory results to develop a simple, non-invasive, and cost-effective way to monitor SLE activity. Participants will include patients with active SLE who meet specific classification criteria, as well as healthy individuals matched by age and sex for comparison. The study involves measuring the albumin to globulin ratio and prognostic nutritional index in these participants to assess their disease activity. The primary outcome is to evaluate the usefulness of AGR as a reliable biomarker for predicting disease activity over a period from six months to one year. During the study, participants will undergo assessments including laboratory tests to measure AGR and PNI. Researchers will track these markers alongside clinical manifestations and other laboratory parameters. The study will monitor outcomes over time to determine if these markers can effectively predict disease activity in SLE. Participation duration and follow-up plans will align with the study timeline ending in June 2026.
CONDITIONS
AGR+PNI as Predictors of Systemic Lupus Erythematosus Disease Activity
H
Hala A Hamid, Master
E
Esam M Abualfadl, Professor
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Sohag University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At baseline
Participants undergo measurement of albumin to globulin ratio and prognostic nutritional index to assess disease activity in systemic lupus erythematosus patients.
1 visit (in-person)
Duration - 6 months to 1 year
Participants are monitored to evaluate the utility of the albumin-to-globulin ratio as a biomarker for disease activity over time.
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Helena Idborg, Susanna Eketjäll, Susanne Pettersson...
https://pubmed.ncbi.nlm.nih.gov/29955370/Xiaoli Guo, Jingjing Shao, Baoqian Zhai...
https://pubmed.ncbi.nlm.nih.gov/32417713/Martin Aringer, Karen Costenbader, David Daikh...
https://pubmed.ncbi.nlm.nih.gov/31383717/Megan R W Barber, Cristina Drenkard, Titilola Falasinnu...
https://pubmed.ncbi.nlm.nih.gov/34345022/Sohag University
Lead Sponsor